Intestinal mononuclear phagocytes as prognostic biomarker for crohn's disease
US-2024425923-A1 · Dec 26, 2024 · US
US12497650B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12497650-B2 |
| Application number | US-202217690796-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 9, 2022 |
| Priority date | Mar 10, 2021 |
| Publication date | Dec 16, 2025 |
| Grant date | Dec 16, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention encompasses methods for reducing the incidence of hemorrhagic heart disease in livestock.
Opening claim text (preview).
I claim: 1 . A method of reducing the incidence of Mulberry heart disease in a Sus scrofa population comprising: identifying selection candidates in the population; for each selection candidate, determining i) an allele of a single nucleotide polymorphism corresponding to position 204959669 of chromosome 13 of Sus scrofa , or ii) an allele of a genetic marker in linkage disequilibrium with the single nucleotide polymorphism wherein the allele of the genetic marker in linkage disequilibrium with the single nucleotide polymorphism is perfectly predictive of an allele of the single nucleotide polymorphism; selecting parents from among the selection candidates based on the determined allele of the single nucleotide polymorphism or based on the determined allele of the genetic marker in linkage disequilibrium with the single nucleotide polymorphism in the population; and producing progeny from the parents. 2 . The method of claim 1 , further comprising the step of correlating the determined allele of the single nucleotide polymorphism or the determined allele of the genetic marker with the risk of Mulberry heart disease in the individual.
for diseases caused by alterations of genetic material · CPC title
Swine · CPC title
Breeding vertebrates · CPC title
Allele-specific amplification · CPC title
Polymorphic or mutational markers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.